Denali Therapeutics
DNLI
#4212
Rank
โ‚ฌ2.21 B
Marketcap
15,04ย โ‚ฌ
Share price
0.28%
Change (1 day)
-35.30%
Change (1 year)

EPS for Denali Therapeutics (DNLI)

EPS in 2025 (TTM): -2,61ย โ‚ฌ

According to Denali Therapeutics 's latest financial reports the company's current EPS (TTM) is -2,48ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -2,19ย โ‚ฌ a decrease over its 2023 EPS that were of -0,89ย โ‚ฌ.

EPS history for Denali Therapeutics from 2017 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-2,61ย โ‚ฌ18.77%
2024-2,19ย โ‚ฌ147.12%
2023-0,89ย โ‚ฌ-60%
2022-2,22ย โ‚ฌ8.79%
2021-2,04ย โ‚ฌ-712.82%
20200,33ย โ‚ฌ-118.93%
2019-1,76ย โ‚ฌ402.44%
2018-0,35ย โ‚ฌ-88.89%
2017-3,15ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novocure
NVCR
-1,37ย โ‚ฌ-44.67% Jersey
Novavax
NVAX
1,81ย โ‚ฌ-172.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
-9,84ย โ‚ฌ 295.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-6,06ย โ‚ฌ 143.99%๐Ÿ‡ฌ๐Ÿ‡ง UK